“I really enjoyed my work. I loved the mission of trying to keep these medical devices safe for everybody who’s going to use them.” Classifications for reported “de novo” medical devices, which tend ...

Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous electroencephalogram (EEG) monitoring ...

Epiminder, a pioneering medical device and information solutions company, today announced that it has been granted FDA authorisation via the De Novo classification for Minder, its proprietary ...

"I really enjoyed my work. I loved the mission of trying to keep these medical devices safe for everybody who's gonna use them." Classifications for reported "de novo" medical devices, which tend ...